$51.870.72%-0.375
Pulse Biosciences Inc (PLSE)
Date: 2026-11-02 16:00O: 52.25H: 52.25L: 51.32C: 51.87Vol: 6.520k
Pulse Biosciences Inc stock is traded at $51.87, with a volume of 15,159. It is down -0.72% in the last 24 hours and up +8.28% over the past month. Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Previous Close:
$52.24
Open:
$52.25
24h Volume:
15,159
Relative Volume:
0.04
Market Cap:
$3.70B
Revenue:
$751.00K
Net Income/Loss:
-$74.57M
P/E Ratio:
-
EPS:
-$1.10
Net Cash Flow:
-$55.52M
1W Performance:
-1.51%
1M Performance:
+8.28%
6M Performance:
+148.99%
1Y Performance:
+206.35%
1-Day Range:
$51.32$52.25
1-Week Range:
$51.39$56.51
52-Week Range:
$12.56$58.90
Pulse Biosciences Inc Stock (PLSE) Company Profile
Name
Pulse Biosciences IncSector
HealthcareIndustry
Medical Instruments & SuppliesPhone
510-906-4600Address
3957 POINT EDEN WAY, HAYWARD, CA, USACompare PLSE vs ISRG, BDX, ALC, RMD, WST
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
Pulse Biosciences Inc Stock (PLSE) Financials Data
Pulse Biosciences Inc Stock (PLSE) Insider Trading
- Teplitsky Liane RaeAug 31 '26Chief Operating Officer
- Transaction
- Buy
- Cost
- $48.80
- #Shares
- 1,024
- Value ($)
- 49,971
- #Shares Total
- 3,094
- Teplitsky Liane RaeAug 28 '26Chief Operating Officer
- Transaction
- Buy
- Cost
- $48.35
- #Shares
- 1,034
- Value ($)
- 49,994
- #Shares Total
- 2,070
- Teplitsky Liane RaeAug 26 '26Chief Operating Officer
- Transaction
- Buy
- Cost
- $48.23
- #Shares
- 1,036
- Value ($)
- 49,971
- #Shares Total
- 1,036
- DUGGAN ROBERT WMay 11 '26Director
- Transaction
- Buy
- Cost
- $19.69
- #Shares
- 660,233
- Value ($)
- 12,999,988
- #Shares Total
- 48,211,433
- LAVIOLETTE PAUL AMay 11 '26Chief Executive Officer
- Transaction
- Buy
- Cost
- $19.69
- #Shares
- 15,000
- Value ($)
- 295,350
- #Shares Total
- 15,000
- Danahy Kevin PatrickFeb 18 '26Chief Commercial Officer
- Transaction
- Option Exercise
- Cost
- $1.53
- #Shares
- 5,000
- Value ($)
- 7,650
- #Shares Total
- 48,298
- Danahy Kevin PatrickFeb 18 '26Chief Commercial Officer
- Transaction
- Sale
- Cost
- $23.64
- #Shares
- 5,000
- Value ($)
- 118,200
- #Shares Total
- 43,298
- Danahy Kevin PatrickFeb 17 '26Chief Commercial Officer
- Transaction
- Sale
- Cost
- $23.63
- #Shares
- 20,000
- Value ($)
- 472,600
- #Shares Total
- 43,298
- Danahy Kevin PatrickFeb 13 '26Chief Commercial Officer
- Transaction
- Sale
- Cost
- $23.53
- #Shares
- 20,000
- Value ($)
- 470,600
- #Shares Total
- 43,298
- Danahy Kevin PatrickFeb 12 '26Chief Commercial Officer
- Transaction
- Sale
- Cost
- $23.37
- #Shares
- 20,000
- Value ($)
- 467,400
- #Shares Total
- 43,298